Dr. Marc Kattelman, D.O. Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: Rr 5 Box 79, Selbyville, DE 19975 Phone: 302-436-9600 Fax: 302-436-6260 |
Dr. Ellen Rowe Rhodes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 37464 Lion Drive, Unit 2, Selbyville, DE 19975 Phone: 302-564-0004 Fax: 302-564-0005 |
Dr. Kristine Marie Griffin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 32427 Lighthouse Rd, Selbyville, DE 19975 Phone: 302-436-9600 Fax: 302-436-6260 |
Dr. Darlene L. Haupt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 36450 Tidal Rd, Selbyville, DE 19975 Phone: 302-291-6045 Fax: 833-449-3867 |
Mrs. Sally Hamel Dowling, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 N Williams St, Selbyville, DE 19975 Phone: 302-436-8004 Fax: 302-436-9769 |
News Archive
The AP/KTVZ.com examines how after years of strained relationships between the "military-run nation" of Myanmar and international donors that led to a large reduction in HIV/AIDS funding, donors are considering reinvesting in the country's HIV/AIDS programs.
Rochester Medical Corporation today announced operating results for its fourth quarter and year ended September 30, 2009.
Fourteen out of every 1,000 COVID-19 patients admitted to hospital experience a stroke, a rate that is even higher in older patients and those with severe infection and pre-existing vascular conditions, according to a report published this week.
E Cigarettes National, one of the top U.S. suppliers and retailers for e cigarette products has announced the upgrade of its already wildly popular site. The upgrade was stated as an attempt to increase the ease of use so that its visitors could find everything they need and make the checkout process seamless and simple.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
› Verified 4 days ago